Pharmaceutical company AstraZeneca plans to sell its antibiotic pills business to Pfizer in a deal that will be valued in excess of $1.5 billion when rights, royalties and other payments are included
ABC News: Money, ABC News: Business
Wed, 08/24/2016 - 10:27am
Pharmaceutical company AstraZeneca plans to sell its antibiotic pills business to Pfizer in a deal that will be valued in excess of $1.5 billion when rights, royalties and other payments are included